---
schema_version: "secwatch.filing_event.v1"
accession: "0001087294-26-000055"
form_type: "8-K"
ticker: "CPIX"
cik: "0001087294"
company_name: "CUMBERLAND PHARMACEUTICALS INC"
filed_at: "2026-07-13T21:28:01+00:00"
generated_at: "2026-07-13T21:30:08.568998+00:00"
event_type: "dividend"
sentiment: "positive"
materiality_score: 0.75
calibrated_materiality_score: 0.75
confidence: "high"
source: SEC EDGAR
---

# Cumberland Pharmaceuticals declares special dividend of $1.50/share, authorizes $5M buyback

## Summary
- Special cash dividend of $1.50 per share, payable July 31, 2026 to holders of record July 23, 2026.
- Board authorized open-market share repurchase program of up to $5 million, replacing prior $10M program.
- Dividend follows $100M cash received from Apotex strategic transaction; up to $11M additional payments expected.
- Several board members plan to establish new share purchase plans to increase holdings.
- Company retains pipeline of ifetroban for Duchenne, systemic sclerosis, IPF, and cancer metastasis.

## SEC filing metadata
- accession: 0001087294-26-000055
- form_type: 8-K
- ticker: CPIX
- cik: 0001087294
- company_name: CUMBERLAND PHARMACEUTICALS INC
- filed_at: 2026-07-13T21:28:01+00:00
- event_type: dividend
- sentiment: positive
- materiality_score: 0.75
- calibrated_materiality_score: 0.75
- confidence: high
- sec_items: 8.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1087294/000108729426000055/0001087294-26-000055-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1087294/000108729426000055/cpix-20260713.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001087294-26-000055
- JSON: https://secwatch.observer/filing/0001087294-26-000055.json
- Plain text: https://secwatch.observer/filing/0001087294-26-000055.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.